Artificial Intelligence for Advance Requesting of Immunohistochemistry in Diagnostically Uncertain Prostate Biopsies

Author:

Chatrian AndreaORCID,Colling Richard TORCID,Browning LisaORCID,Alham Nasullah KhalidORCID,Sirinukunwattana KorsukORCID,Malacrino Stefano,Haghighat MaryamORCID,Aberdeen AlanORCID,Monks Amelia,Moxley-Wyles BenjaminORCID,Rakha EmadORCID,Snead David R JORCID,Rittscher JensORCID,Verrill ClareORCID

Abstract

ABSTRACTThe use of immunohistochemistry in the reporting of prostate biopsies is an important adjunct when the diagnosis is not definite on haematoxylin and eosin (H&E) morphology alone. The process is however inherently inefficient with delays while waiting for pathologist review to make the request and duplicated effort reviewing a case more than once. In this study, we aimed to capture the workflow implications of immunohistochemistry requests and demonstrate a novel artificial intelligence tool to identify cases in which immunohistochemistry (IHC) is required and generate an automated request.We conducted audits of the workflow for prostate biopsies in order to understand the potential implications of automated immunohistochemistry requesting and collected prospective cases to train a deep neural network algorithm to detect tissue regions that presented ambiguous morphology on whole slide images. These ambiguous foci were selected on the basis of the pathologist requesting immunohistochemistry to aid diagnosis. A gradient boosted trees classifier was then used to make a slide level prediction based on the outputs of the neural network prediction. The algorithm was trained on annotations of 219 immunohistochemistry-requested and 80 control images, and tested by 3-fold cross-validation. Validation was conducted on a separate validation dataset of 212 images.Non IHC-requested cases were diagnosed in 17.9 minutes on average, while IHC-requested cases took 33.4 minutes over multiple reporting sessions. We estimated 11 minutes could be saved on average per case by automated IHC requesting, by removing duplication of effort. The tool attained 99% accuracy and 0.99 Area Under the Curve (AUC) on the test data. In the validation, the average agreement with pathologists was 0.81, with a mean AUC of 0.80.We demonstrate the proof-of-principle that an AI tool making automated immunohistochemistry requests could create a significantly leaner workflow and result in pathologist time savings.

Publisher

Cold Spring Harbor Laboratory

Reference34 articles.

1. World Cancer Research Fund. Worldwide cancer data [Internet]. [cited 2021 January 12]. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/worldwide-cancer-data.

2. CRUK. Prostate cancer statistics [Internet]. [cited 2021 January 12]. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer#heading-Three

3. Royal College of Pathologists. Histopathology Workforce Survey 2018. 2018. [cited 2021 January 12]. Available from: https://www.rcpath.org/profession/workforce-planning/our-workforce-research/histopathology-workforce-survey-2018.html.

4. Cross, T. and S. McPhail , National Institute for Health and Clinical Excellence: Guidance, in Prostate Cancer: Diagnosis and Treatment (Supplement): An Assessment of Need. 2008, National Collaborating Centre for Cancer (UK) Copyright © 2008, National Collaborating Centre for Cancer.: Cardiff (UK).

5. Complications After Prostate Biopsy: Data From SEER-Medicare

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3